hotspot -WSS

hotspot

author：entertainment 2025-10-01 02:14:56 - browse：48

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Canadians with cystic fibrosis outlive Americans by a decade

Wikipedia

hotspot

WSS

A letter from the executive editor: The 2023 STATUS List

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Hubble vs. James Webb telescope images: See the difference

What causes rare myocarditis in young men after Covid vaccines?

Democrats decry new health bill for going easy on private equity

The haunting brain science of long Covid

Wikipedia

hotspot

explore

After affirmative action ruling, medical educators look to 'holistic review'

New Alzheimer's drugs heat up race for early detection blood tests

Cancer drug shortages should be causing more outrage

The biotech scorecard for Q3: 15 stock

Medical records are filled with copy

Will the FTC rein in IQVIA's health data empire?

Dobbs anniversary: the lost opportunity of abortion as health care

Biden warns of ‘dark winter’ during final presidental debate

Medicare details structure of new drug price negotiation program

A letter from the executive editor: The 2023 STATUS List

hotspot

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

New lawsuit accuses health insurer Cigna of denying claims in bulk

STAT Report: Patient voices and perspectives

The biotech scorecard for Q3: 15 stock

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Will the FTC rein in IQVIA's health data empire?

hotspot

Wikipedia

hotspot

explore